BUBS Naturals of Encinitas, CA is voluntarily recalling certain lots of its Fountain of Youth Formula Collagen Protein (“Fountain of Youth Product”) due to undeclared milk. People who have an...

The FDA is responsible for protecting the public health by ensuring the safety, efficacy, and security of human and veterinary drugs, biological products, and medical devices; and by ensuring...

2022年7月7日 · An emergency policy in the United States to allow fast-tracked imports of international infant formula from companies such as Bubs (ASX: BUB) is now on track to becoming a more permanent fixture, following the latest regulatory moves from the Food and Drug Administration (FDA).

Aussie Bubs – yes, Aussie Bubs Toddler formulas are FDA label compliant and they are also produced in our fully company owned and controlled, FDA registered site. Bubs Australia –The US Government & FDA have recently approved Bubs Australia Infant Formula products to be imported to the US to support with the current infant formula shortage.

2022年5月27日 · Today the FDA announced efforts to receive over one million cans of infant formula from the Australian company Aussie Bubs (Bubs Australia), in addition to this past week’s approval of Kendal...

All of our formulas are regulated by the FDA, comply with all Australian State & Federal Regulatory and export quality control requirements, and are GSFI certified (Global certification standard FSSC 22000), a certifying standard recognized globally for high-quality requirements.

2024年9月17日 · “Bubs will transition from ‘temporary enforcement discretion’ to permanent market access, upon FDA approval, expected in October 2025,” the company wrote on Tuesday. The clinical trial is US-wide and referred to as a “Growth, Tolerance and Safety” study.

To increase the diversity of and support a stable supply of infant formula in the U.S., the FDA is providing a pathway for manufacturers of infant formula products that were imported, sold,...

2023年9月7日 · In line with the regulatory timeline, Bubs plans to submit results from the GMS to the FDA by September 2024 with a full infant formula submission by October 2024. The ongoing partnership with the FDA and formal processes associated with regulatory approval continue to be an operational and strategic priority for Bubs’ management team.

2022年5月16日 · Bubs received FDA regulatory acknowledgement as a manufacturer under the Enforcement Discretion Program for six infant formula products. This was our first step toward bringing a steady formula supply to the states.